HELLS and hepatocellular carcinoma: Similarly, Law’s team observed decreased growth and metastatic ability of hepatocellular carcinoma (HCC) in both in vitro and in vivo experiments by knocking down the deconjugating enzyme HELLS (Helicase Lymphoid-Specific) (Law et al., 2019), which revealed the critical role of epigenetic factors in tumor progression.